Fundacion de la Comunidad Valenciana Centro de Investigacion Principe Felipe

Fundacion de la Comunidad Valenciana Centro de Investigacion Principe Felipe is a research organisation in Valencia, Spain that has taken part in 31 EU-funded projects since 2008, receiving €13.8M in EU funding and leading 9 as coordinator.

EU funding received€13.8M
EU projects31
As coordinator9
Running now13
First EU project2008
Latest project2027
CountrySpain
EU registration (PIC)999430965
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Fundacion de la Comunidad Valenciana Centro de Investigacion Principe Felipe's own share of each project, not the project's full budget.

  • Horizon Europe€7.9M · 13 projects
  • Horizon 2020€3.1M · 7 projects
  • FP7 (2007 to 2013)€2.7M · 9 projects
  • EU4Health Programme (EU4H)€91k · 1 project
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

31 EU-funded projects, newest first. Fundacion de la Comunidad Valenciana Centro de Investigacion Principe Felipe led 9 of them as coordinator. Each links to the official record.

  • ReCoTAPartner

    Reconfigurable Colloids For Therapeutic Applications

    Horizon Europe · 2027–2031 · Project on CORDIS ↗

    €282ktheir share
  • EVOLVECoordinator

    Deconvolution of tumor evolution and ecosystem through EV-based liquid biopsy

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €2.0Mtheir share
  • MORPHEUSCoordinator

    Mechano-metabOlic Responsive nanoPlatform for HeterogEnous tUmor Suppression

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €2.5Mtheir share
  • EACHAssociated partner

    Excellence in Analytical Chemistry

    Erasmus+ (ERASMUS+) · 2025–2031 · Project on the EU portal ↗

  • eCAN PlusAssociated partner

    Enhancing the digital capabilities of cancer centres in Europe to improve prevention and care

    EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗

    €91ktheir share
  • NanoBiCarAssociated partner

    NanoBiCar: A novel immunotherapy for infectious diseases

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • NATPRIMEPartner

    Effective Delivery of Nucleic Acid Therapeutics via Designed Nanocarriers

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €504ktheir share
  • UNLOOCPartner

    Unlocking data content of Organ-On-Chips

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €90ktheir share
  • AFRODITAAssociated partner

    Advancing Fertility and Reproduction thrOugh Dedicated and Innovative Technological Applications

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • IMPULSEPartner

    IMProving User experience, Long-term sustainability and Services of EU-OPENSCREEN

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €143ktheir share
  • EDC-MASLDPartner

    Investigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver disease

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €459ktheir share
  • REGUBIOMECoordinator

    Transcriptional REGUlation as a mediator of bacterial interactions in the microBIOME

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.5Mtheir share
  • TherACCageAssociated partner

    Therapeutic Artificial Cells based on Molecular Cages for Glioblastoma Treatment

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

  • MultiSMARTPartner

    Multi-component Soft Materials Advanced Research Training Network

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €252ktheir share
  • POLYBRAINTCoordinator

    Versatile Polypeptide-based Intranasal Drug Delivery Platform(s) to Tackle CNS Disorders.

    Horizon Europe · 2022–2023 · Project on CORDIS ↗

    €150ktheir share
  • RISEUPPartner

    Regeneration of Injured Spinal cord by Electro pUlsed bio-hybrid imPlant

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €508ktheir share
  • BIOMOLMACSPartner

    Molecular Machines Functioning in Cells

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €251ktheir share
  • EU-OPENSCREEN-DRIVEPartner

    Ensuring long-term sustainability of excellence in chemical biology within Europe and beyond

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €81ktheir share
  • POLYMMUNECoordinator

    Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment

    Horizon 2020 · 2019–2020 · Project on CORDIS ↗

    €150ktheir share
  • StemBATPartner

    New players in human BAT differentiation and activation: a human PSC-derived BAT approach combined with state of the art genome engineering and –omics based methodologies

    Horizon 2020 · 2016–2023 · Project on CORDIS ↗

    €347ktheir share
  • EPICPartner

    Exploiting Protein Complexes that Induce Cell-death

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €27ktheir share
  • MyNanoCoordinator

    Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

    €1.7Mtheir share
  • DEANNCoordinator

    Developing an European American NGS Network

    FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗

    €216ktheir share
  • MLPM2012Partner

    Machine Learning for Personalized Medicine

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €235ktheir share
  • STATegraCoordinator

    User-driven Development of Statistical Methods for Experimental Planning, Data Gathering, and Integrative Analysis of Next Generation Sequencing, Proteomics and Metabolomics data

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €576ktheir share
  • EUROCONDORPartner

    European Consortium for the Early Treatment of Diabetic Retinopathy

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €76ktheir share
  • DENAMICPartner

    Developmental neurotoxicity assessment of mixtures in children

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €649ktheir share
  • InnovaLivPartner

    Innovative strategies to generate human hepatocytes for treatment ofmetabolic Liver diseases: Tools for personalized cell therapy

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €255ktheir share
  • LIVIMODEPartner

    Light-based functional in vivo monitoring of diseases related enzymes

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €303ktheir share
  • LIV-ESPartner

    Development of culture conditions for the differentiation of hES cells into hepatocytes

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €281ktheir share
  • HESC METABONOMICSCoordinator

    Elucidation of Stem Cell Fate and Cell-type Characterization by 1H-NMR-based Metabonomics

    FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗

    €153ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • adverse drug reactions
  • alkaline earth metals
  • antibiotic resistance
  • antibiotics
  • anxiety disorders
  • bacteriology
  • biosensors
  • breast cancer
  • carbohydrates
  • cell biology
  • data science
  • databases
  • drug discovery

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime